Switzerland is world famous for its pharmaceutical industry. There are many different pharmaceutical companies all over Switzerland. In the following we present 3 from the canton of Zurich. Zurich is also considered the hotspot of the pharmaceutical industry. All 3 are part of our list of the 100 largest pharmaceutical companies in Switzerland.
- Contains the 100 top-selling pharmaceutical companies from Switzerland from numerous segments such as immunotherapeutics, gynecology, biopharmaceuticals, oncology, OTC drugs, generics, urology, tumor therapy, antibiotics, etc.
- Excellent level of detail: industry and field of activity, sales if publicly available (2020, 2019, 2018, 2017, 2016, 2015), number of employees if publicly available, general contact details, names of executives, etc.
- Free preview available on request via contact [at] researchgermany.de or live chat.
1. Medinova AG, Zurich-Oerlikon: CHF 5.4 billion turnover (DKHS Healthcare Division)
Medinova was founded in 1945 on the premises of a Zurich pharmacy. At that time, the company’s goal was to manufacture pharmaceutical specialties and synthesize chemical raw materials. Today, the company focuses on prescription drugs and over-the-counter products in the fields of gynecology and dermatology. Medinova deliberately sees itself as a niche supplier. Production is contract manufacturing, and Medinova takes care of marketing. In addition to the Swiss market, the company is also active in Germany, Poland and Russia. Since 2004, Medinova has been part of the Swiss trading and services group DKHS (Healthcare Business Unit).
2. Vifor Pharma Management Ltd., Opfikon-Glattbrugg: CHF 1.7 billion turnover
Vifor Pharma emerged from the former Galenica Group. The Swiss healthcare and logistics company was split into Vifor Pharma and Galenica Santé in 2014. Galenica Santé went public on the stock exchange. The Vifor Pharma division continued to operate independently as Vifor Pharma Group. The company’s most important product area is iron deficiency products. This accounts for 40 to 50 percent of sales. In addition, the product portfolio includes medicines for the treatment of kidney diseases and in the field of cardiorenal diseases (simultaneous heart and kidney diseases). The Group employs more than 2,600 people.
3. Acino International AG, Zurich: > CHF 450 million turnover
The Swiss company Acino is focused on the production of generic drugs and pharmaceutical specialties. The company’s history began in 1836 with the discovery of a common salt deposit near Basel. Acino started there as a saline, but became a chemical factory just a few years later. Today, the company specializes in the development and manufacture of generic and patent-protected drugs with new dosage forms (oral delivery with modified release of active ingredient, medical patches, biodegradable subcutaneous implants). In addition to manufacturing for its own marketing, Acino also undertakes contract manufacturing. The company employs nearly 2,600 people.
Picture Source: Unsplash ( Patrick Federi, 14.12.21)